- Home
- FRPH vs RLAY Comparison
FRPH vs RLAY Comparison
Compare FRPH & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- RLAY
- Stock Information
- Founded
- FRPH 1986
- RLAY 2015
- Country
- FRPH United States
- RLAY United States
- Employees
- FRPH N/A
- RLAY N/A
- Industry
- FRPH Real Estate
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FRPH Finance
- RLAY Health Care
- Exchange
- FRPH Nasdaq
- RLAY Nasdaq
- Market Cap
- FRPH 537.8M
- RLAY 620.4M
- IPO Year
- FRPH N/A
- RLAY 2020
- Fundamental
- Price
- FRPH $28.57
- RLAY $2.62
- Analyst Decision
- FRPH
- RLAY Strong Buy
- Analyst Count
- FRPH 0
- RLAY 10
- Target Price
- FRPH N/A
- RLAY $19.33
- AVG Volume (30 Days)
- FRPH 43.8K
- RLAY 2.5M
- Earning Date
- FRPH 03-05-2025
- RLAY 05-01-2025
- Dividend Yield
- FRPH N/A
- RLAY N/A
- EPS Growth
- FRPH 20.77
- RLAY N/A
- EPS
- FRPH 0.34
- RLAY N/A
- Revenue
- FRPH $30,415,000.00
- RLAY $10,007,000.00
- Revenue This Year
- FRPH N/A
- RLAY N/A
- Revenue Next Year
- FRPH N/A
- RLAY $544.28
- P/E Ratio
- FRPH $84.78
- RLAY N/A
- Revenue Growth
- FRPH 2.86
- RLAY N/A
- 52 Week Low
- FRPH $26.99
- RLAY $2.45
- 52 Week High
- FRPH $33.00
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- FRPH 43.01
- RLAY 32.07
- Support Level
- FRPH $28.43
- RLAY $3.05
- Resistance Level
- FRPH $29.10
- RLAY $3.08
- Average True Range (ATR)
- FRPH 0.76
- RLAY 0.25
- MACD
- FRPH 0.09
- RLAY -0.04
- Stochastic Oscillator
- FRPH 72.11
- RLAY 11.64
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).